Prevest Denpro Limited
BSE: PREVEST
Prev Close
544.45
Open Price
539
Volume
2,200
Today Low / High
539 / 562.55
52 WK Low / High
393.6 / 686
Range
534 - 591
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 562.55, reflecting a change of 18.1 (3.32446%). The expected target range on the BSE is 534 - 591. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Prevest Denpro Limited Graph
Prevest Denpro Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Prevest Denpro Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 562.55, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 562.55 | 568.18 | 511.36 - 624.99 |
| 573.80 | 459.04 - 688.56 | ||
| 579.43 | 405.60 - 753.25 | ||
| Bearish Scenario | 562.55 | 556.92 | 501.23 - 612.62 |
| 551.30 | 441.04 - 661.56 | ||
| 545.67 | 381.97 - 709.38 |
Overview of Prevest Denpro Limited
ISIN
INE0GAO01018
Industry
Medical - Specialties
Vol.Avg
8,553
Market Cap
6,752,287,650
Last Dividend
1
Official Website
IPO Date
DCF Diff
120.81
DCF
442
Financial Ratios Every Investor Needs
Stock Dividend of PREVEST
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-03 | September 03, 25 | 1 | 1 | 2025-09-03 | 2025-10-09 | |
| 2024-08-30 | August 30, 24 | 1 | 1 | 2024-08-30 | 2024-10-06 | |
| 2023-08-23 | August 23, 23 | 1 | 1 | 2023-08-23 | 2023-09-29 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 63.03 Cr | 12.25 Cr | 50.78 Cr | 0.8056 | 0.00 Cr | 0.00 Cr | 20.18 Cr | 18.16 Cr | 15.12 | 26.15 Cr | 0.2880 |
| 2024-03-31 | 55.91 Cr | 13.56 Cr | 42.35 Cr | 0.7575 | 0.00 Cr | 1.41 Cr | 18.78 Cr | 16.14 Cr | 13.45 | 22.92 Cr | 0.2886 |
| 2023-03-31 | 49.85 Cr | 19.06 Cr | 30.80 Cr | 0.6178 | 0.01 Cr | 1.03 Cr | 19.39 Cr | 15.71 Cr | 13.09 | 21.84 Cr | 0.3151 |
| 2022-03-31 | 38.11 Cr | 9.78 Cr | 28.33 Cr | 0.7434 | 0.01 Cr | 1.03 Cr | 14.70 Cr | 11.57 Cr | 9.64 | 16.84 Cr | 0.3036 |
| 2021-03-31 | 27.44 Cr | 12.21 Cr | 15.23 Cr | 0.5550 | 0.16 Cr | 6.51 Cr | 8.57 Cr | 7.21 Cr | 8.16 | 10.06 Cr | 0.2626 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 60.90 Cr | 112.53 Cr | 6.96 Cr | 105.5718 Cr | 0.00 Cr | -60.90 Cr | 8.04 Cr | 26.81 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 5.9617 Cr |
| 2024-03-31 | 48.61 Cr | 94.82 Cr | 6.20 Cr | 88.6175 Cr | 0.00 Cr | -48.61 Cr | 6.24 Cr | 26.75 Cr | 0.32 Cr | 0.00 Cr | 0.00 Cr | 5.5114 Cr |
| 2023-03-31 | 39.00 Cr | 78.61 Cr | 5.81 Cr | 72.7975 Cr | 0.00 Cr | -39.00 Cr | 6.08 Cr | 24.29 Cr | 1.05 Cr | 0.00 Cr | 0.00 Cr | 5.4404 Cr |
| 2022-03-31 | 42.32 Cr | 64.14 Cr | 7.05 Cr | 57.0874 Cr | 1.37 Cr | -40.95 Cr | 5.76 Cr | 11.44 Cr | 0.84 Cr | 0.00 Cr | 0.00 Cr | 5.3994 Cr |
| 2021-03-31 | 16.42 Cr | 30.68 Cr | 8.18 Cr | 22.4960 Cr | 1.39 Cr | -15.03 Cr | 1.96 Cr | 7.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 6.5464 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 14.8174 Cr | -1.3290 Cr | -1.2003 Cr | 12.8491 Cr | 12.2881 Cr | 60.8984 Cr | -1.9683 Cr | 24.2497 Cr | 0.0000 Cr | -1.2003 Cr | -1.7946 Cr |
| 2024-03-31 | 11.6248 Cr | -1.7008 Cr | -0.3168 Cr | 7.8934 Cr | 9.6072 Cr | 48.6103 Cr | -3.7314 Cr | 16.1369 Cr | 0.0000 Cr | -0.3168 Cr | -1.4515 Cr |
| 2023-03-31 | 10.6671 Cr | -12.3772 Cr | -1.3667 Cr | -1.2451 Cr | -3.3333 Cr | 39.0031 Cr | -13.5277 Cr | 15.7101 Cr | -1.3667 Cr | 0.0000 Cr | -1.5252 Cr |
| 2022-03-31 | 8.1743 Cr | -3.8657 Cr | 22.8182 Cr | 3.2834 Cr | 25.9147 Cr | 42.3364 Cr | -4.8909 Cr | 11.5688 Cr | -0.0272 Cr | 0.0000 Cr | -1.9905 Cr |
| 2021-03-31 | 8.7563 Cr | -1.9269 Cr | -0.5689 Cr | 6.8503 Cr | 6.1258 Cr | 16.4217 Cr | -2.2318 Cr | 7.2067 Cr | -0.2508 Cr | 0.0000 Cr | -0.1428 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 18.45 Cr | 2.45 Cr | 16.00 Cr | 0.8670 | 6.08 Cr | 5.14 Cr | 4.28 | 7.62 Cr | 0.2786 |
| 2024-12-31 | 14.95 Cr | 3.28 Cr | 11.67 Cr | 0.7806 | 4.73 Cr | 4.53 Cr | 3.77 | 6.30 Cr | 0.3028 |
| 2024-09-30 | 16.27 Cr | 3.71 Cr | 12.56 Cr | 0.7722 | 5.34 Cr | 4.82 Cr | 4.01 | 6.85 Cr | 0.2959 |
| 2024-06-30 | 13.36 Cr | 5.97 Cr | 7.38 Cr | 0.5529 | 4.04 Cr | 3.67 Cr | 3.06 | 5.38 Cr | 0.2750 |
| 2024-03-31 | 16.24 Cr | 6.66 Cr | 9.57 Cr | 0.5895 | 5.53 Cr | 4.77 Cr | 3.98 | 6.84 Cr | 0.2940 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 60.90 Cr | 4.70 Cr | 65.60 Cr | 9.77 Cr | 8.04 Cr | 85.72 Cr | 26.81 Cr | 112.53 Cr | 6.96 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 59.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -95.91 Cr |
| 2024-09-30 | 55.95 Cr | 3.78 Cr | 59.73 Cr | 7.88 Cr | 6.71 Cr | 76.23 Cr | 26.44 Cr | 102.67 Cr | 6.76 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 50.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -88.62 Cr |
| 2024-03-31 | 48.61 Cr | 1.66 Cr | 50.27 Cr | 8.26 Cr | 7.34 Cr | 68.07 Cr | 26.75 Cr | 94.82 Cr | 6.20 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 4.53 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 4.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 3.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 4.77 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 3.64 Cr | 3.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 3.64 Cr | 0.00 Cr | 0.00 Cr | 3.64 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Specialties
No stocks found in this industry.
Key Executives
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1978
Gender: male
Year Born: 1953
Gender: male
Year Born:
Gender: female
Year Born: 1958
FAQs about Prevest Denpro Limited
The CEO is Atul Modi.
The current price is ₹562.55.
The range is ₹393.6-686.
The market capitalization is ₹675.23 crores.
The dividend yield is 0.18%.
The P/E ratio is 37.20.
The company operates in the Healthcare sector.
Overview of Prevest Denpro Limited (ISIN: INE0GAO01018) is a leading Medical - Specialties in India. With a market capitalization of ₹675.23 crores and an average daily volume of 8,553 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹1.